Cargando…
Development and Immunogenicity of a Prototype Multivalent Group B Streptococcus Bioconjugate Vaccine
[Image: see text] Group B Streptococcus (GBS) is a leading cause of neonatal infections and invasive diseases in nonpregnant adults worldwide. Developing a protective conjugate vaccine targeting the capsule of GBS has been pursued for more than 30 years; however, it has yet to yield a licensed produ...
Autores principales: | Duke, Jeremy A., Paschall, Amy V., Robinson, Lloyd S., Knoot, Cory J., Vinogradov, Evgeny, Scott, Nichollas E., Feldman, Mario F., Avci, Fikri Y., Harding, Christian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793035/ https://www.ncbi.nlm.nih.gov/pubmed/34633812 http://dx.doi.org/10.1021/acsinfecdis.1c00415 |
Ejemplares similares
-
Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae
por: Wantuch, Paeton L., et al.
Publicado: (2023) -
A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae
por: Feldman, Mario F., et al.
Publicado: (2019) -
Discovery and characterization of a new class of O-linking oligosaccharyltransferases from the Moraxellaceae family
por: Knoot, Cory J, et al.
Publicado: (2022) -
A minimal sequon sufficient for O-linked glycosylation by the versatile oligosaccharyltransferase PglS
por: Knoot, Cory J, et al.
Publicado: (2021) -
Therapeutic Activity of Type 3 Streptococcus pneumoniae Capsule Degrading Enzyme Pn3Pase
por: Paschall, Amy V., et al.
Publicado: (2020)